{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:44:45Z","timestamp":1790675085638,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.revmed.2011.01.002","type":"journal-article","created":{"date-parts":[[2011,3,7]],"date-time":"2011-03-07T17:24:21Z","timestamp":1299518661000},"page":"689-697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Hypertension art\u00e9rielle pulmonaire associ\u00e9e au lupus syst\u00e9mique"],"prefix":"10.1016","volume":"32","author":[{"given":"L.","family":"Arnaud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Agard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Haroche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Cacoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-C.","family":"Piette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Amoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2011.01.002_bib0005","unstructured":"Haute autorit\u00e9 de sant\u00e9. Hypertension art\u00e9rielle pulmonaire, protocole national de diagnostic et de soins pour une maladie rare. 1997."},{"key":"10.1016\/j.revmed.2011.01.002_bib0010","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1183\/09031936.00139009","article-title":"Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"34","author":"Galie","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2011.01.002_bib0015","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/j.jacc.2004.02.037","article-title":"Clinical classification of pulmonary hypertension","volume":"43","author":"Simonneau","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.revmed.2011.01.002_bib0020","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1002\/art.21433","article-title":"Early detection of pulmonary arterial hypertension in systemic sclerosis: a french nationwide prospective multicenter study","volume":"52","author":"Hachulla","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2011.01.002_bib0025","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary arterial hypertension in france: results from a national registry","volume":"173","author":"Humbert","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2011.01.002_bib0030","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s10067-006-0206-5","article-title":"Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension","volume":"25","author":"Chung","year":"2006","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.revmed.2011.01.002_bib0035","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1002\/art.22265","article-title":"Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus","volume":"54","author":"Farzaneh-Far","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2011.01.002_bib0040","doi-asserted-by":"crossref","unstructured":"Fo\u00efs E.\u00a0Pr\u00e9valence de l\u2019hypertension arterielle pulmonaire dans le lupus erythemateux systemique. D\u00e9pistage par \u00e9chocardiographie. [th\u00e8se]. Paris: Universit\u00e9 Paris 11; 2006.","DOI":"10.1016\/j.revmed.2006.10.045"},{"key":"10.1016\/j.revmed.2011.01.002_bib0045","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1191\/0961203303lu1051oa","article-title":"Pulmonary hypertension in systemic lupus","volume":"13","author":"Johnson","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2011.01.002_bib0050","first-page":"1923","article-title":"Pulmonary hypertension in systemic lupus erythematosus: clinical association and survival in 18\u00a0patients","volume":"26","author":"Li","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2011.01.002_bib0055","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1191\/096120300678828361","article-title":"Primary and secondary pulmonary hypertension in systemic lupus erythematosus","volume":"9","author":"Pan","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2011.01.002_bib0060","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s002960050074","article-title":"Pulmonary hypertension in systemic lupus erythematosus","volume":"18","author":"Shen","year":"1999","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.revmed.2011.01.002_bib0065","first-page":"918","article-title":"Pulmonary hypertension in systemic lupus erythematosus","volume":"16","author":"Simonson","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2011.01.002_bib0070","first-page":"282","article-title":"Pulmonary hypertension in systemic lupus erythematosus: evaluation of clinical characteristics and response to immunosuppressive treatment","volume":"29","author":"Tanaka","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2011.01.002_bib0075","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/0002-8703(95)90278-3","article-title":"Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus","volume":"129","author":"Winslow","year":"1995","journal-title":"Am Heart J"},{"key":"10.1016\/j.revmed.2011.01.002_bib0080","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/rheumatology\/kep203","article-title":"Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus","volume":"48","author":"Prabu","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2011.01.002_bib0085","first-page":"1292","article-title":"Pulmonary hypertension in a lupus clinic: experience with twenty-four patients","volume":"17","author":"Asherson","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2011.01.002_bib0090","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0049-0172(81)90098-6","article-title":"Pulmonary hypertension in systemic lupus erythematosus: report of four cases and review of the literature","volume":"11","author":"Perez","year":"1981","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.revmed.2011.01.002_bib0095","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0049-0172(84)90015-5","article-title":"Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus","volume":"13","author":"Quismorio","year":"1984","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.revmed.2011.01.002_bib0100","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.ehj.2004.09.014","article-title":"Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The task force on diagnosis and treatment of pulmonary arterial hypertension of the european society of cardiology","volume":"25","author":"Galie","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.revmed.2011.01.002_bib0105","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/000331978503600705","article-title":"Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100\u00a0patients","volume":"36","author":"Badui","year":"1985","journal-title":"Angiology"},{"key":"10.1016\/j.revmed.2011.01.002_bib0110","first-page":"477","article-title":"Precapillary pulmonary arterial hypertension disclosing systemic lupus erythematosus","volume":"89","author":"Fauchier","year":"1996","journal-title":"Arch Mal Coeur Vaiss"},{"key":"10.1016\/j.revmed.2011.01.002_bib0115","first-page":"2161","article-title":"Pulmonary venoocclusive disease in a patient with systemic lupus erythematosus","volume":"20","author":"Kishida","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2011.01.002_bib0120","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1191\/0961203305lu2206oa","article-title":"Pulmonary arterial hypertension associated to connective tissue diseases","volume":"14","author":"Galie","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2011.01.002_bib0125","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1378\/chest.130.1.182","article-title":"Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension","volume":"130","author":"Sanchez","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2011.01.002_bib0130","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/0961203307087188","article-title":"An update in pulmonary hypertension in systemic lupus erythematosus \u2013 do we need to know about it?","volume":"17","author":"Pope","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2011.01.002_bib0135","doi-asserted-by":"crossref","first-page":"25S","DOI":"10.1016\/j.jacc.2004.02.033","article-title":"Pathologic assessment of vasculopathies in pulmonary hypertension","volume":"43","author":"Pietra","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.revmed.2011.01.002_bib0140","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1172\/JCI1910","article-title":"Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension","volume":"101","author":"Lee","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2011.01.002_bib0145","first-page":"467","article-title":"Pulmonary hypertension associated with systemic lupus erythematosus: predominantly thrombotic arteriopathy accompanied by plexiform lesions","volume":"122","author":"Yokoi","year":"1998","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.revmed.2011.01.002_bib0150","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/ajcp\/65.3.284","article-title":"Pulmonary vascular disease in systemic lupus erythematosus","volume":"65","author":"Fayemi","year":"1976","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.revmed.2011.01.002_bib0155","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0002-9343(81)90366-1","article-title":"The lung in systemic lupus erythematosus. Analysis of the pathologic changes in 120\u00a0patients","volume":"71","author":"Haupt","year":"1981","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2011.01.002_bib0160","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000196025","article-title":"Plexogenic arteriopathy associated with pulmonary vasculitis in systemic lupus erythematosus","volume":"59","author":"Roncoroni","year":"1992","journal-title":"Respiration"},{"key":"10.1016\/j.revmed.2011.01.002_bib0165","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.humpath.2006.11.022","article-title":"Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases","volume":"38","author":"Dorfmuller","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1016\/j.revmed.2011.01.002_bib0170","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/ard.34.5.457","article-title":"Lupus cor pulmonale with electron microscope and immunofluroescent antibody studies","volume":"34","author":"Yeo","year":"1975","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2011.01.002_bib0175","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1002\/art.10487","article-title":"Mutations of bone morphogenetic protein receptor type ii are not found in patients with pulmonary hypertension and underlying connective tissue diseases","volume":"46","author":"Tew","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2011.01.002_bib0180","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7326\/0003-4819-107-2-216","article-title":"Primary pulmonary hypertension. A national prospective study","volume":"107","author":"Rich","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2011.01.002_bib0185","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/1529-0131(200102)44:2<376::AID-ANR56>3.0.CO;2-2","article-title":"Anti-topoisomerase i (anti-scl-70) antibodies in patients with systemic lupus erythematosus","volume":"44","author":"Gussin","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2011.01.002_bib0190","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S1568-9972(02)00063-0","article-title":"Antiendothelial cell antibodies in systemic lupus erythematosus","volume":"1","author":"Renaudineau","year":"2002","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2011.01.002_bib0195","first-page":"2058","article-title":"Antiendothelial cell antibodies and their relation to pulmonary hypertension in systemic lupus erythematosus","volume":"21","author":"Yoshio","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2011.01.002_bib0200","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1172\/JCI2261","article-title":"The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis","volume":"101","author":"Bordron","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2011.01.002_bib0205","first-page":"286","article-title":"High prevalence of antiphospholipid antibodies in precapillary pulmonary hypertension","volume":"23","author":"Karmochkine","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2011.01.002_bib0210","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1034\/j.1399-3003.2000.15b28.x","article-title":"Thrombotic risk factors in pulmonary hypertension","volume":"15","author":"Wolf","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2011.01.002_bib0215","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0002-9343(94)90108-2","article-title":"Comparison of the primary and secondary antiphospholipid syndrome: a european multicenter study of 114\u00a0patients","volume":"96","author":"Vianna","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2011.01.002_bib0220","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/ard.61.3.195","article-title":"The lung in the antiphospholipid syndrome","volume":"61","author":"Espinosa","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2011.01.002_bib0225","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1191\/0961203303lu530xx","article-title":"Systemic lupus erythematosus in tunisia: demographic and clinical analysis of 100\u00a0patients","volume":"13","author":"Houman","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2011.01.002_bib0230","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2169\/internalmedicine.41.109","article-title":"Severe pulmonary hypertension in a patient with systemic lupus erythematosus and minimal lupus activity","volume":"41","author":"Kawamura","year":"2002","journal-title":"Intern Med"},{"key":"10.1016\/j.revmed.2011.01.002_bib0235","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/1529-0131(200104)44:4<902::AID-ANR147>3.0.CO;2-9","article-title":"Pulmonary capillary endothelial dysfunction in early systemic sclerosis","volume":"44","author":"Orfanos","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2011.01.002_bib0240","first-page":"1963","article-title":"Anti-endothelial cell autoantibodies and soluble markers of endothelial cell dysfunction in systemic lupus erythematosus","volume":"30","author":"Constans","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2011.01.002_bib0245","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3181\/00379727-199-43342","article-title":"Endothelin 1: mitogenic activity on pulmonary artery smooth muscle cells and release from hypoxic endothelial cells","volume":"199","author":"Hassoun","year":"1992","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.revmed.2011.01.002_bib0250","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.revmed.2009.11.011","article-title":"Le syst\u00e8me endoth\u00e9line\u00a0: son implication dans le syst\u00e8me cardiovasculaire","volume":"31","author":"Belaidi","year":"2010","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2011.01.002_bib0255","first-page":"1566","article-title":"Significance of plasma endothelin-1\u00a0levels in patients with systemic sclerosis","volume":"19","author":"Yamane","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2011.01.002_bib0260","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000204684","article-title":"Effect of total-body cold exposure on plasma concentrations of von willebrand factor, endothelin-1\u00a0and thrombomodulin in systemic lupus erythematosus patients with or without raynaud's phenomenon","volume":"88","author":"Matsuda","year":"1992","journal-title":"Acta Haematol"},{"key":"10.1016\/j.revmed.2011.01.002_bib0265","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ki.1995.61","article-title":"Effect of a specific endothelin a receptor antagonist on murine lupus nephritis","volume":"47","author":"Nakamura","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.revmed.2011.01.002_bib0270","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/ard.54.5.361","article-title":"Endothelin-1\u00a0release from cultured endothelial cells induced by sera from patients with systemic lupus erythematosus","volume":"54","author":"Yoshio","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2011.01.002_bib0275","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/1529-0131(199805)41:5<800::AID-ART5>3.0.CO;2-J","article-title":"Arterial disease and thrombosis in the antiphospholipid syndrome: a pathogenic role for endothelin 1","volume":"41","author":"Atsumi","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2011.01.002_bib0280","first-page":"539","article-title":"Causes of death in korean patients with systemic lupus erythematosus: a single center retrospective study","volume":"17","author":"Kim","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2011.01.002_bib0285","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1183\/09031936.04.00079704","article-title":"Chronic thromboembolic pulmonary hypertension","volume":"23","author":"Dartevelle","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2011.01.002_bib0290","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM199207093270203","article-title":"The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension","volume":"327","author":"Rich","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2011.01.002_bib0295","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1161\/CIRCULATIONAHA.104.488486","article-title":"Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension","volume":"111","author":"Sitbon","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.revmed.2011.01.002_bib0300","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The primary pulmonary hypertension study group","volume":"334","author":"Barst","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2011.01.002_bib0305","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-132-6-200003210-00002","article-title":"Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial","volume":"132","author":"Badesch","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2011.01.002_bib0310","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1183\/09031936.99.13613579","article-title":"Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study","volume":"13","author":"Humbert","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2011.01.002_bib0315","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1378\/chest.117.1.14","article-title":"Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus","volume":"117","author":"Robbins","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2011.01.002_bib0320","doi-asserted-by":"crossref","first-page":"118","DOI":"10.47102\/annals-acadmedsg.V32N1p118","article-title":"Intermittent epoprostenol infusions in systemic lupus erythematosus associated pulmonary hypertension\u2013a series of three cases","volume":"32","author":"Kong","year":"2003","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.revmed.2011.01.002_bib0325","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s10067-005-0170-5","article-title":"Low-dose epoprostenol improved pulmonary hypertension in a patient with systemic lupus erythematosus","volume":"26","author":"Matsukawa","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.revmed.2011.01.002_bib0330","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/S0755-4982(05)84207-1","article-title":"Treatment for pulmonary arterial hypertension under the new french hospital financing system Recommendations of the pulmonary vascular diseases working group of the French society of pulmonary medicine","volume":"34","author":"Sitbon","year":"2005","journal-title":"Presse Med"},{"key":"10.1016\/j.revmed.2011.01.002_bib0335","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1378\/chest.126.2.420","article-title":"Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease","volume":"126","author":"Oudiz","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2011.01.002_bib0340","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa020204","article-title":"Inhaled iloprost for severe pulmonary hypertension","volume":"347","author":"Olschewski","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2011.01.002_bib0345","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1136\/ard.2005.048967","article-title":"Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: A subgroup analysis of the pivotal clinical trials and their open-label extensions","volume":"65","author":"Denton","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2011.01.002_bib0350","first-page":"299","article-title":"Two-years therapy with bosentan of pulmonary arterial hypertension related to connective tissue diseases","volume":"59","author":"Marotta","year":"2007","journal-title":"Reumatismo"},{"key":"10.1016\/j.revmed.2011.01.002_bib0355","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/0961203307076509","article-title":"Bosentan use in systemic lupus erythematosus patients with pulmonary arterial hypertension","volume":"16","author":"Mok","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2011.01.002_bib0360","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1136\/ard.2007.069609","article-title":"Selective endothelin a receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease","volume":"66","author":"Girgis","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2011.01.002_bib0365","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jacc.2005.04.050","article-title":"Ambrisentan therapy for pulmonary arterial hypertension","volume":"46","author":"Galie","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.revmed.2011.01.002_bib0370","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1161\/CIRCULATIONAHA.107.742510","article-title":"Ambrisentan for the treatment of pulmonary arterial hypertension: Results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (aries) study 1\u00a0and 2","volume":"117","author":"Galie","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.revmed.2011.01.002_bib0375","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/j.jacc.2009.07.033","article-title":"Long-term ambrisentan therapy for the treatment of pulmonary arterial hypertension","volume":"54","author":"Oudiz","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.revmed.2011.01.002_bib0380","first-page":"2417","article-title":"Sildenafil for pulmonary arterial hypertension associated with connective tissue disease","volume":"34","author":"Badesch","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2011.01.002_bib0385","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/CIRCULATIONAHA.108.839274","article-title":"Tadalafil therapy for pulmonary arterial hypertension","volume":"119","author":"Galie","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.revmed.2011.01.002_bib0390","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1191\/0961203304lu509oa","article-title":"Therapy with intermittent pulse cyclophosphamide for pulmonary hypertension associated with systemic lupus erythematosus","volume":"13","author":"Gonzalez-Lopez","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2011.01.002_bib0395","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1378\/chest.104.6.1903","article-title":"Prolonged survival after heart-lung transplantation in systemic lupus erythematosus","volume":"104","author":"Levy","year":"1993","journal-title":"Chest"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866311000257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866311000257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:28:51Z","timestamp":1759336131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866311000257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":79,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0248866311000257"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2011.01.002","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypertension art\u00e9rielle pulmonaire associ\u00e9e au lupus syst\u00e9mique","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2011.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Soci\u00e9t\u00e9 nationale fran\u00e7aise de m\u00e9decine interne (SNFMI). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}